Illuminating the Noncoding Genome in Cancer Using Artificial Intelligence.

Journal: Cancer research
Published Date:

Abstract

Understanding the vast noncoding cancer genome requires cutting-edge, high-resolution, and accessible strategies. Artificial intelligence is revolutionizing cancer research, enabling advanced models to analyze genome regulation. This review examines illustrative examples of noncoding mutations in cancer, focusing on both key regulatory elements and risk-associated variants that remain poorly understood, and compares key artificial intelligence models developed over the last decade for identifying functional noncoding variants, predicting gene expression impacts, and uncovering cancer-associated mutations. The discussion of the goals, data requirements, features, and outcomes of the models offers practical insights to help cancer researchers integrate these technologies into their work, regardless of computational expertise. This article is part of a special series: Driving Cancer Discoveries with Computational Research, Data Science, and Machine Learning/AI.

Authors

  • Maria Del Mar Álvarez-Torres
    Biomedical Data Science Laboratory, ITACA, Universitat Politècnica de València, Valencia, Spain.
  • Xi Fu
    Department of Oncology, Pidu District People's Hospital, Chengdu, Sichuan, China.
  • Raul Rabadan
    Department of Systems Biology, Columbia University, New York, NY 10032 USA.